AIDX - 20/20 Biolabs Inc
1.4567
0.087 5.952%
Share volume: 193,676
Last Updated: 05-12-2026
Business Services/Services – Research, Development, Testing Labs:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$1.37
0.09
0.06%
Fundamental analysis
0%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
0%
Performance
5 Days
6.33%
1 Month
-21.26%
3 Months
-93.89%
6 Months
-93.89%
1 Year
-93.89%
2 Year
-93.89%
Key data
Stock price
$1.46
DAY RANGE
$1.37 - $1.66
52 WEEK RANGE
$1.32 - $50.00
52 WEEK CHANGE
-$93.89
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Jonathan Cohen
Region: US
Website: 2020biolabs.com
Employees: 14
IPO year: 2026
Issue type:
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services
Region: US
Website: 2020biolabs.com
Employees: 14
IPO year: 2026
Issue type:
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services
We develop and commercialize AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. Our principal executive offices are located in Gaithersburg, MD.
Recent news